Rüdiger Smolnik - Concepedia

Author

Rüdiger Smolnik

Daiichi Sankyo (Germany)

Also Known As

R S Smolnik, R Smolnik, Rüdiger Smolnik, Rudiger Smolnik, Rüdiger Smolnik, Rüdiger Smolnik

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Daiichi Sankyo (Germany)University of Lübeck München Klinik Atrial Fibrillation NETwork Hasselt University

About

Rüdiger Smolnik is an author at Daiichi Sankyo (Germany) specializing in medicine, pharmacotherapy, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	869
2	Social Sciences	3	3	54
3	Public Health	2	2	804
4	Neurology	2	2	180
5	Endocrinology	1	1	31

Rüdiger Smolnik

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial Pascal Vranckx, Marco Valgimigli, Lars Eckardt, The Lancet ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseEntrust-af PciPharmacology	2019	636
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference Renate B. Schnabel, Elena Andreassi Marinelli, Elena Arbelo, EP Europace	2022	174
Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial Stefan H. Hohnloser, A. John Camm, Riccardo Cappato, European Heart Journal Cardiovascular PharmacologyEdoxaban TherapyPharmacotherapyEliminate-af TrialK Antagonists	2019	168
The Melanocortin Melanocyte-Stimulating Hormone/Adrenocorticotropin<sub>4–10</sub>Decreases Body Fat in Humans<sup>1</sup> Horst L. Fehm, Rüdiger Smolnik, Werner Kern, The Journal of Clinical Endocrinology & Metabolism	2001	113
Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial Pascal Vranckx, Thorsten Lewalter, Marco Valgimigli, American Heart Journal	2017	86
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference Larissa Fabritz, Harry J.G.M. Crijns, Eduard Guasch, EP Europace	2020	66
Overweight Humans Are Resistant to the Weight-Reducing Effects of Melanocortin4–10 Manfred Hallschmid, Rüdiger Smolnik, G.P. McGregor, The Journal of Clinical Endocrinology & Metabolism	2006	35
Brain Potentials and Attention after Acute and Subchronic Intranasal Administration of ACTH 4–10 and Desacetyl-α-MSH in Humans Rüdiger Smolnik, Matthias Mölle, Horst L. Fehm, Neuroendocrinology	1999	32
Melatonin Acutely Improves the Neuroendocrine Architecture of Sleep in Blind Individuals Stefan Fischer, Rüdiger Smolnik, Markus Herms, The Journal of Clinical Endocrinology & Metabolism Sleep DisordersSleep HealthMg MelatoninSocial SciencesSleep Medicine	2003	31
Enhanced Selective Attention After Low-Dose Administration of the Benzodiazepine Antagonist Flumazenil Rüdiger Smolnik, Reinhard Pietrowsky, Horst L. Fehm, Journal of Clinical Psychopharmacology	1998	31

Page 1